Follow
Kate M. Johnson
Kate M. Johnson
Assistant Professor, University of British Columbia
Verified email at ubc.ca - Homepage
Title
Cited by
Cited by
Year
The acute COPD exacerbation prediction tool (ACCEPT): a modelling study
A Adibi, DD Sin, A Safari, KM Johnson, SD Aaron, JM FitzGerald, ...
The Lancet Respiratory Medicine 8 (10), 1013-1021, 2020
302020
Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis
KM Johnson, S Bryan, S Ghanbarian, DD Sin, M Sadatsafavi
Respiratory Research 19 (1), 26, 2018
242018
A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma
K Al Efraij, KM Johnson, D Wiebe, M Sadatsafavi, JM FitzGerald
Journal of Asthma 56 (12), 1334-1346, 2019
212019
The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
M Sadatsafavi, H Xie, M Etminan, KM Johnson, JM FitzGerald, ...
PloS one 13 (1), e0191243, 2018
212018
Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study
KM Johnson, W Chen, JM FitzGerald, M Sadatsafavi, WD Leslie
Archives of Osteoporosis 13 (1), 116, 2018
13*2018
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
KM Johnson, A Safari, WC Tan, J Bourbeau, JM FitzGerald, M Sadatsafavi
International Journal of Chronic Obstructive Pulmonary Disease 13, 3983, 2018
122018
Demographic effects on fruit set in the dioecious shrub Canada buffaloberry (Shepherdia canadensis)
KM Johnson, SE Nielsen
PeerJ 2, e526, 2014
112014
Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
MS Hamid Tavakoli, Kate M Johnson, J Mark FitzGerald, Don D Sin, Andrea S ...
International Journal of Chronic Obstructive Pulmonary Disease 2019 (14 …, 2019
10*2019
Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for Canada
M Sadatsafavi, S Ghanbarian, A Adibi, KM Johnson, JM FitzGerald, ...
Medical Decision Making, 0272989X18824098, 2019
102019
Stability of asthma symptom control in a longitudinal study of mild-moderate asthmatics
KM Johnson, JM FitzGerald, H Tavakoli, W Chen, M Sadatsafavi
The Journal of Allergy and Clinical Immunology: In Practice 5 (6), 1663-1670. e5, 2017
92017
Demographic consequences of invasion by a native, controphic competitor to an insular bird population
KM Johnson, RR Germain, CE Tarwater, JM Reid, P Arcese
Oecologia 187 (1), 155-165, 2018
72018
Cost effectiveness of case detection strategies for the early detection of COPD
KM Johnson, M Sadatsafavi, A Adibi, L Lynd, M Harrison, H Tavakoli, ...
Applied Health Economics and Health Policy 19 (2), 203-215, 2021
62021
Nest defense and parental investment in Song Sparrows (Melospiza melodia)
N Morrell, KM Johnson, CE Tarwater, P Arcese
Canadian Journal of Zoology 94 (7), 473-477, 2016
52016
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States
M Yaghoubi, A Adibi, Z Zafari, JM FitzGerald, SD Aaron, KM Johnson, ...
Journal of Allergy and Clinical Immunology 145 (5), 1367-1377. e4, 2020
42020
The diagnostic performance of patient symptoms in screening for COPD
KM Johnson, WC Tan, J Bourbeau, DD Sin, M Sadatsafavi
Respiratory Research 19 (1), 147, 2018
42018
Healthcare system encounters before COPD diagnosis: a registry-based longitudinal cohort study
KM Johnson, A Khakban, S Bryan, DD Sin, M Sadatsafavi
Thorax 75 (2), 108-115, 2020
32020
Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
B Ng, M Sadatsafavi, A Safari, JM FitzGerald, KM Johnson
BMJ open 9 (11), e031306, 2019
22019
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
KM Johnson, B Jiao, MA Bender, SD Ramsey, B Devine, A Basu
PloS one 17 (4), e0267448, 2022
2022
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
Z Baldwin, B Jiao, A Basu, J Roth, MA Bender, Z Elsisi, KM Johnson, ...
PharmacoEconomics-Open, 1-13, 2022
2022
A longitudinal approach to assessing patterns of healthcare utilization
KM Johnson
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 1-2, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20